Jubilant Therapeutics

About Jubilant Therapeutics

Jubilant Therapeutics develops selective small molecule modulators targeting genetically-defined cancers and autoimmune disorders, focusing on specific genetic mutations and drug resistance mechanisms. The company aims to meet unmet medical needs by advancing its clinical-stage programs through strategic partnerships and fast-tracking them from discovery to pivotal studies.

Jubilant Therapeutics develops selective small molecule modulators targeting genetically-defined cancers and autoimmune disorders, focusing on specific genetic mutations and drug resistance mechanisms. The company aims to meet unmet medical needs by advancing its clinical-stage programs through strategic partnerships and fast-tracking them from discovery to pivotal studies.

What does Jubilant Therapeutics do?

Jubilant Therapeutics develops selective small molecule modulators targeting genetically-defined cancers and autoimmune disorders, focusing on specific genetic mutations and drug resistance mechanisms. The company aims to meet unmet medical needs by advancing its clinical-stage programs through strategic partnerships and fast-tracking them from discovery to pivotal studies.

Where is Jubilant Therapeutics located?

Jubilant Therapeutics is based in Bedminster, United States.

When was Jubilant Therapeutics founded?

Jubilant Therapeutics was founded in 2019.

Location
Bedminster, United States
Founded
2019
Employees
12 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

Start Searching

Jubilant Therapeutics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Jubilant Therapeutics develops selective small molecule modulators targeting genetically-defined cancers and autoimmune disorders, focusing on specific genetic mutations and drug resistance mechanisms. The company aims to meet unmet medical needs by advancing its clinical-stage programs through strategic partnerships and fast-tracking them from discovery to pivotal studies.

jubilanttx.com3K+
Founded 2019 – Bedminster, United States

Funding

No funding information available.

Team (10+)

No team information available.

Company Description

Jubilant Therapeutics develops selective small molecule modulators targeting genetically-defined cancers and autoimmune disorders, focusing on specific genetic mutations and drug resistance mechanisms. The company aims to meet unmet medical needs by advancing its clinical-stage programs through strategic partnerships and fast-tracking them from discovery to pivotal studies.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.